BRPI0612169A2 - métodos prognósticos, métodos de detecção, de distinção, de identificação, de determinação e de monitoramento relacionados com cáncer de pulmão, métodos para amplificação de um ácido nucléico que codifica c-met humano , biomarcadores de cáncer de pulmão, agentes de imagem de cáncer de pulmão, polinucleotìdeos, agente s de ligação de antìgeno, conjuntos, meios legìveis em computador e kits e/ou artigos de fabricação - Google Patents
métodos prognósticos, métodos de detecção, de distinção, de identificação, de determinação e de monitoramento relacionados com cáncer de pulmão, métodos para amplificação de um ácido nucléico que codifica c-met humano , biomarcadores de cáncer de pulmão, agentes de imagem de cáncer de pulmão, polinucleotìdeos, agente s de ligação de antìgeno, conjuntos, meios legìveis em computador e kits e/ou artigos de fabricação Download PDFInfo
- Publication number
- BRPI0612169A2 BRPI0612169A2 BRPI0612169-1A BRPI0612169A BRPI0612169A2 BR PI0612169 A2 BRPI0612169 A2 BR PI0612169A2 BR PI0612169 A BRPI0612169 A BR PI0612169A BR PI0612169 A2 BRPI0612169 A2 BR PI0612169A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- lung cancer
- determination
- polynucleotides
- articles
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
MéTODOS PROGNóSTICOS, MéTODOS DE DETECçãO, DE DISTINçãO, DE IDENTIFICAçãO, DE DETERMINAçãO E DE MONITORAMENTO RELACIONADOS COM CáNCER DE PULMãO, MéTODOS PARA AMPLIFICAçãO DE UM áCIDO NUCLéICO QUE CODIFICA C-MET HUMANO, BIOMARCADORES DE CáNCER DE PULMãO, AGENTES DE IMAGEM DE CáNCER DE PULMãO, POLINUCLEOTIDEOS, AGENTES DE LIGAçãO DE ANTIGENO, CONJUNTOS, MEIOS LEGIVEIS EM COMPUTADOR E KITS E/OU ARTIGOS DE FABRICAçãO. A presente invenção fornece métodos e composições úteis para detectar mutações em c-met em células de câncer de pulmão.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66531705P | 2005-03-25 | 2005-03-25 | |
PCT/US2006/010851 WO2006104912A2 (en) | 2005-03-25 | 2006-03-24 | C-met mutations in lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0612169A2 true BRPI0612169A2 (pt) | 2010-10-19 |
Family
ID=36512935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0612169-1A BRPI0612169A2 (pt) | 2005-03-25 | 2006-03-24 | métodos prognósticos, métodos de detecção, de distinção, de identificação, de determinação e de monitoramento relacionados com cáncer de pulmão, métodos para amplificação de um ácido nucléico que codifica c-met humano , biomarcadores de cáncer de pulmão, agentes de imagem de cáncer de pulmão, polinucleotìdeos, agente s de ligação de antìgeno, conjuntos, meios legìveis em computador e kits e/ou artigos de fabricação |
Country Status (13)
Country | Link |
---|---|
US (2) | US20060263808A1 (pt) |
EP (1) | EP1861513A2 (pt) |
JP (1) | JP2008533991A (pt) |
KR (1) | KR20080004514A (pt) |
CN (1) | CN101180410A (pt) |
AU (1) | AU2006229990A1 (pt) |
BR (1) | BRPI0612169A2 (pt) |
CA (1) | CA2600283A1 (pt) |
IL (1) | IL185666A0 (pt) |
MX (1) | MX2007011650A (pt) |
RU (1) | RU2007139516A (pt) |
WO (1) | WO2006104912A2 (pt) |
ZA (1) | ZA200707946B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200707953B (en) | 2005-03-25 | 2009-06-24 | Genenthech Inc | Methods and compositions for modulating hyperstabilized c-met |
US20080160533A1 (en) * | 2006-11-30 | 2008-07-03 | Abbott Laboratories | Assay for prediction of response to Met antagonists |
WO2008113013A2 (en) * | 2007-03-15 | 2008-09-18 | University Of Chicago | C-met mutations and uses thereof |
WO2011056505A1 (en) | 2009-10-26 | 2011-05-12 | Abbott Laboratories | Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancer |
US20130004484A1 (en) | 2011-06-30 | 2013-01-03 | Genentech, Inc. | Anti-c-met antibody formulations |
KR20130036993A (ko) * | 2011-10-05 | 2013-04-15 | 삼성전자주식회사 | c-Met의 SEMA 도메인 내의 에피토프에 특이적으로 결합하는 항체 |
KR101753833B1 (ko) | 2012-01-09 | 2017-07-05 | 사회복지법인 삼성생명공익재단 | 절단 가능한 프로브를 이용한 만성골수성백혈병 유전자의 멀티플렉스 검출 방법 |
KR101404682B1 (ko) | 2012-01-09 | 2014-06-10 | 사회복지법인 삼성생명공익재단 | 절단 가능한 프로브를 이용한 c―Met 유전자 검출 방법 |
KR101938698B1 (ko) | 2012-07-23 | 2019-01-16 | 삼성전자주식회사 | Cbl의 항 c-met 항체 적용 대상 환자 선별을 위한 바이오마커로서의 용도 |
RU2016141385A (ru) | 2014-03-24 | 2018-04-28 | Дженентек, Инк. | Лечение рака антагонистами с-мет и их корреляция с экспрессией hgf |
EP3221468B1 (en) * | 2014-11-20 | 2020-03-25 | Stichting Katholieke Universiteit | A novel auto-active and intracellular mutant of met |
CN113150147A (zh) | 2015-03-16 | 2021-07-23 | 塞尔德克斯医疗公司 | 抗-met抗体及其使用方法 |
CN105713987A (zh) * | 2016-04-25 | 2016-06-29 | 北京福安华生物科技有限公司 | 一种检测人类met基因14外显子剪接突变的引物、探针及试剂盒 |
KR101977351B1 (ko) * | 2016-09-21 | 2019-05-10 | 사회복지법인 삼성생명공익재단 | 항암제 저항성 또는 민감성 예측용 조성물 |
CN106757379B (zh) * | 2016-12-20 | 2018-08-28 | 上海赛安生物医药科技股份有限公司 | 肺癌多基因变异文库构建方法 |
GB201714748D0 (en) * | 2017-09-13 | 2017-10-25 | Univ Oxford Innovation Ltd | Single-molecule phenotyping and sequencing of nucleic acid molecules |
CN108315431A (zh) * | 2018-05-04 | 2018-07-24 | 良培基因生物科技(武汉)有限公司 | 数字PCR技术检测c-MET基因扩增的引物、探针及其检测方法 |
CN108893536B (zh) * | 2018-07-13 | 2022-02-15 | 江苏省人民医院(南京医科大学第一附属医院) | 一种从人外周血CTC中检测c-MET基因拷贝数变异的方法和试剂盒 |
CN108929908A (zh) * | 2018-07-17 | 2018-12-04 | 张丽英 | 一种基于数字PCR平台c-MET基因Exon14跳读的检测方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000510330A (ja) * | 1996-04-05 | 2000-08-15 | トーマス・ジェファーソン・ユニバーシティ | 癌の診断および予後のための方法 |
CA2258153C (en) * | 1996-07-03 | 2004-08-17 | Genentech, Inc. | Hepatocyte growth factor receptor agonists and uses thereof |
KR20040101502A (ko) * | 2002-04-16 | 2004-12-02 | 제넨테크, 인크. | 종양의 진단 및 치료 방법 및 이를 위한 조성물 |
PL1636593T3 (pl) * | 2003-06-06 | 2009-08-31 | Genentech Inc | Modulowanie oddziaływania pomiędzy łańcuchem beta HGF i c-met. |
JP2008507252A (ja) * | 2003-12-11 | 2008-03-13 | ジェネンテック・インコーポレーテッド | C−met二量体化及び活性化を阻害するための方法と組成物 |
-
2006
- 2006-03-24 AU AU2006229990A patent/AU2006229990A1/en not_active Abandoned
- 2006-03-24 MX MX2007011650A patent/MX2007011650A/es not_active Application Discontinuation
- 2006-03-24 US US11/388,773 patent/US20060263808A1/en not_active Abandoned
- 2006-03-24 EP EP06739565A patent/EP1861513A2/en not_active Withdrawn
- 2006-03-24 JP JP2008503237A patent/JP2008533991A/ja not_active Withdrawn
- 2006-03-24 RU RU2007139516/13A patent/RU2007139516A/ru not_active Application Discontinuation
- 2006-03-24 CA CA002600283A patent/CA2600283A1/en not_active Abandoned
- 2006-03-24 ZA ZA200707946A patent/ZA200707946B/xx unknown
- 2006-03-24 CN CNA2006800179354A patent/CN101180410A/zh active Pending
- 2006-03-24 WO PCT/US2006/010851 patent/WO2006104912A2/en active Application Filing
- 2006-03-24 BR BRPI0612169-1A patent/BRPI0612169A2/pt not_active Application Discontinuation
- 2006-03-24 KR KR1020077024500A patent/KR20080004514A/ko not_active Application Discontinuation
-
2007
- 2007-09-03 IL IL185666A patent/IL185666A0/en unknown
-
2009
- 2009-02-09 US US12/367,804 patent/US20090155807A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090155807A1 (en) | 2009-06-18 |
EP1861513A2 (en) | 2007-12-05 |
AU2006229990A2 (en) | 2006-10-05 |
WO2006104912A2 (en) | 2006-10-05 |
CN101180410A (zh) | 2008-05-14 |
MX2007011650A (es) | 2008-01-16 |
IL185666A0 (en) | 2008-01-06 |
WO2006104912A3 (en) | 2007-01-11 |
RU2007139516A (ru) | 2009-04-27 |
JP2008533991A (ja) | 2008-08-28 |
WO2006104912A9 (en) | 2007-03-15 |
CA2600283A1 (en) | 2006-10-05 |
ZA200707946B (en) | 2009-02-25 |
AU2006229990A1 (en) | 2006-10-05 |
KR20080004514A (ko) | 2008-01-09 |
US20060263808A1 (en) | 2006-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0612169A2 (pt) | métodos prognósticos, métodos de detecção, de distinção, de identificação, de determinação e de monitoramento relacionados com cáncer de pulmão, métodos para amplificação de um ácido nucléico que codifica c-met humano , biomarcadores de cáncer de pulmão, agentes de imagem de cáncer de pulmão, polinucleotìdeos, agente s de ligação de antìgeno, conjuntos, meios legìveis em computador e kits e/ou artigos de fabricação | |
GB2478441A (en) | Lung cancer biomarkers and uses thereof | |
MX355020B (es) | Biomarcadores de cancer de pulmon y usos de los mismos. | |
SG141418A1 (en) | Method for the detection of gene transcripts in blood and uses thereof | |
NZ593514A (en) | p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer | |
CY1119526T1 (el) | Εμπλουτισμος και ταυτοποιηση εμβρυϊκων κυτταρων σε μητρικο αιμα και προσδετες για τετοια χρηση | |
BRPI0607508A2 (pt) | métodos e ácidos nucléicos para análise de distúrbios proliferativos celulares | |
BRPI0720371B8 (pt) | métodos para diagnóstico ou monitoramento da progressão de câncer de próstata em um indivíduo e uso in vitro de pelo menos um homeodomínio contendo o fator de transcrição como um biomarcador para câncer de próstata | |
WO2008154098A3 (en) | Reagents and methods for mirna expression analysis and identification of cancer biomarkers | |
WO2012177945A3 (en) | Diagnostic methods for eosinophilic esophagitis | |
NZ701807A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
DE602006020544D1 (de) | Apolipoprotein-a-ii-isoform als biomarker für prostatakrebs | |
WO2010129934A3 (en) | Methods and compositions for diagnosis of thyroid conditions | |
BR112012009879A2 (pt) | "métodos diagnósticos para determinar o prognóstico de câncer de pulmão de não pequenos células" | |
NZ599214A (en) | Multigene prognostic assay for lung cancer | |
EA035451B9 (ru) | Способ диагностики рака с использованием геномного секвенирования | |
SG179122A1 (en) | Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis | |
EP4282405A3 (en) | Detection of cancer biomarkers using nanoparticles | |
BR112016004320A2 (pt) | biossensor, sistema, kit, métodos de determinação ou de identificação e de quantificação de uma concentração de amônia ou íon amônio, de diagnóstico de uma doença metabólica em um sujeito, de determinação da resposta do paciente a uma terapia, de fabricação de um biossensor, de um sistema ou de qualquer tira de teste e de detecção da presença, ausência, ou quantidade de aminoácidos em uma amostra, e, tira de teste | |
BRPI0809958B8 (pt) | conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico | |
WO2008048508A3 (en) | Prognostic biomarkers in patients with ovarian cancer | |
WO2019024579A1 (zh) | 用于检测肺癌的基因标志物、试剂盒及肺癌检测方法 | |
Rana | Crime investigation through DNA methylation analysis: methods and applications in forensics | |
WO2009003706A3 (en) | Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones | |
Lee et al. | A collaborative exercise on DNA methylation-based age prediction and body fluid typing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |